Department of Neuroscience, Biomedicum, Karolinska Institutet, Stockholm, Sweden.
Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Str. 9, 60438, Frankfurt am Main, Germany.
Cell Death Dis. 2022 Mar 7;13(3):214. doi: 10.1038/s41419-022-04653-8.
The extremophile Alvinella pompejana, an annelid worm living on the edge of hydrothermal vents in the Pacific Ocean, is an excellent model system for studying factors that govern protein stability. Low intrinsic stability is a crucial factor for the susceptibility of the transcription factor p53 to inactivating mutations in human cancer. Understanding its molecular basis may facilitate the design of novel therapeutic strategies targeting mutant p53. By analyzing expressed sequence tag (EST) data, we discovered a p53 family gene in A. pompejana. Protein crystallography and biophysical studies showed that it has a p53/p63-like DNA-binding domain (DBD) that is more thermostable than all vertebrate p53 DBDs tested so far, but not as stable as that of human p63. We also identified features associated with its increased thermostability. In addition, the A. pompejana homolog shares DNA-binding properties with human p53 family DBDs, despite its evolutionary distance, consistent with a potential role in maintaining genome integrity. Through extensive structural and phylogenetic analyses, we could further trace key evolutionary events that shaped the structure, stability, and function of the p53 family DBD over time, leading to a potent but vulnerable tumor suppressor in humans.
生活在太平洋海底热液喷口边缘的极端嗜热环节虫 Alvinella pompejana 是研究控制蛋白质稳定性因素的理想模型系统。内在稳定性低是人类癌症中转录因子 p53 易发生失活突变的关键因素。了解其分子基础可能有助于设计针对突变 p53 的新型治疗策略。通过分析表达序列标签 (EST) 数据,我们在 A. pompejana 中发现了一个 p53 家族基因。蛋白质晶体学和生物物理研究表明,它具有 p53/p63 样 DNA 结合域 (DBD),比迄今为止测试的所有脊椎动物 p53 DBD 都更耐热,但不如人类 p63 稳定。我们还确定了与它的耐热性增加相关的特征。此外,尽管进化距离较远,但 A. pompejana 同源物与人类 p53 家族 DBD 具有 DNA 结合特性,这与其在维持基因组完整性方面的潜在作用一致。通过广泛的结构和系统发育分析,我们可以进一步追溯塑造 p53 家族 DBD 结构、稳定性和功能的关键进化事件,导致人类中出现一种强大但脆弱的肿瘤抑制因子。
BMC Genomics. 2010-11-16
Appl Environ Microbiol. 2001-1
Biochim Biophys Acta. 2005-3-10
Biomol NMR Assign. 2016-4
ACS Pharmacol Transl Sci. 2025-5-7
Cell Death Differ. 2025-2
Cell Death Discov. 2024-8-7
Nat Rev Clin Oncol. 2024-2
Cancer Cell. 2021-2-8
Cell Death Dis. 2018-5-1
Nat Rev Cancer. 2017-12-15
BMC Evol Biol. 2017-8-3
J Mol Cell Biol. 2017-2-1